Premium
Pharmaceutical cost‐sharing systems and savings for healthcare systems from parallel trade
Author(s) -
Birg Laura
Publication year - 2018
Publication title -
the world economy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.594
H-Index - 68
eISSN - 1467-9701
pISSN - 0378-5920
DOI - 10.1111/twec.12616
Subject(s) - indemnity , cost sharing , reimbursement , economics , health care , actuarial science , drug prices , scheme (mathematics) , public economics , business , economic growth , medicine , nursing , mathematical analysis , mathematics
This paper studies the consequences of parallel trade in a two‐country model. It compares a coinsurance scheme (consumers pay a percentage of the drug price) and an indemnity insurance scheme (reimbursement is independent of the drug price) with respect to changes in copayments and public health expenditure. In the destination country, copayments for patients decrease to a larger extent under indemnity insurance, whereas reductions in public health expenditure occur only under coinsurance. In the source country, copayments increase less under coinsurance, whereas health expenditure is reduced more under indemnity insurance. In both countries, total expenditure under parallel trade is lower.